T. Justin Clark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
T. Justin Clark has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Jane Daniels
Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
3 shared publicationsKs Khan
Women’s Health and Clinical Epidemiology, Barts and the London School of Medicine, London, UK
3 shared publicationsElaine Denny
Centre for Health and Social Care Research, Birmingham City University, Birmingham, UK
2 shared publicationsJanesh K. Gupta
2 shared publicationsJk Gupta
Department of Obstetrics & Gynaecology, Birmingham Women’s Hospital, Birmingham, UK
2 shared publications- Khalid Saeed Khan
University of Granada
2 shared publications
Latest Publications
- Open Access
- 17 May 2016
- Published by Springer Nature in Gynecological Surgery
- Vol. 13 (4) , 313-322
A patient-preference cohort study of office versus inpatient uterine polyp treatment for abnormal uterine bleeding
Uterine polyps can cause abnormal bleeding in women. Conventional practise is to remove them under general anaesthesia but advances in technology have made it possible to perform polypectomy in the office setting. We conducted a patient-preference study to explore women’s preferences for treatment setting and to evaluate the effectiveness and treatment experience of women undergoing uterine polypectomy. Three hundred ninety-nine women with abnormal uterine bleeding who were found to have uterine polyps at diagnostic hysteroscopy were recruited. Office polypectomies were performed in office hysteroscopy clinics, and inpatient procedures were undertaken in operating theatres. Three hundred twenty-four of 399 (81 %) expressed a preference for office treatment. There was no difference found between office treatment and inpatient treatment in terms of alleviating abnormal uterine bleeding as assessed by patients and in improving disease-specific quality of life. Acceptability was lower and patient pain scores were significantly higher in the office group. When offered a choice of treatment setting for uterine polypectomy, patients have a preference for office over inpatient treatment. Ambulatory gynaecology services should be available within healthcare systems to meet patient demand.
- 17 May 2016
- Published by Springer Nature in Gynecological Surgery
- Vol. 13 (4) , 313-322
Open AccessA patient-preference cohort study of office versus inpatient uterine polyp treatment for abnormal uterine bleeding
Uterine polyps can cause abnormal bleeding in women. Conventional practise is to remove them under general anaesthesia but advances in technology have made it possible to perform polypectomy in the office setting. We conducted a patient-preference study to explore women’s preferences for treatment setting and to evaluate the effectiveness and treatment experience of women undergoing uterine polypectomy. Three hundred ninety-nine women with abnormal uterine bleeding who were found to have uterine polyps at diagnostic hysteroscopy were recruited. Office polypectomies were performed in office hysteroscopy clinics, and inpatient procedures were undertaken in operating theatres. Three hundred twenty-four of 399 (81 %) expressed a preference for office treatment. There was no difference found between office treatment and inpatient treatment in terms of alleviating abnormal uterine bleeding as assessed by patients and in improving disease-specific quality of life. Acceptability was lower and patient pain scores were significantly higher in the office group. When offered a choice of treatment setting for uterine polypectomy, patients have a preference for office over inpatient treatment. Ambulatory gynaecology services should be available within healthcare systems to meet patient demand.
- Open Access
Outpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study
Objective To compare the effectiveness and acceptability of outpatient polypectomy with inpatient polypectomy. Design Pragmatic multicentre randomised controlled non-inferiority study. Setting Outpatient hysteroscopy clinics in 31 UK National Health Service hospitals. Participants 507 women who attended as outpatients for diagnostic hysteroscopy because of abnormal uterine bleeding and were found to have uterine polyps. Interventions Participants were randomly assigned to either outpatient uterine polypectomy under local anaesthetic or inpatient uterine polypectomy under general anaesthesia. Data were collected on women’s self reported bleeding symptoms at baseline and at 6, 12, and 24 months. Data were also collected on pain and acceptability of the procedure at the time of polypectomy. Main outcome measures The primary outcome was successful treatment, determined by the women’s assessment of bleeding at six months, with a prespecified non-inferiority margin of 25%. Secondary outcomes included generic (EQ-5D) and disease specific (menorrhagia multi-attribute scale) quality of life, and feasibility and acceptability of the procedure. Results 73% (166/228) of women in the outpatient group and 80% (168/211) in the inpatient group reported successful treatment at six months (intention to treat relative risk 0.91, 95% confidence interval 0.82 to 1.02; per protocol relative risk 0.92, 0.82 to 1.02). Failure to remove polyps was higher (19% v 7%; relative risk 2.5, 1.5 to 4.1) and acceptability of the procedure was lower (83% v 92%; 0.90, 0.84 to 0.97) in the outpatient group Quality of life did not differ significantly between the groups. Four uterine perforations, one of which necessitated bowel resection, all occurred in the inpatient group. Conclusions Outpatient polypectomy was non-inferior to inpatient polypectomy. Failure to remove a uterine polyp was, however, more likely with outpatient polypectomy and acceptability of the procedure was slightly lower. Trial registration International Clinical Trials Registry 65868569.
Open AccessOutpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study
Objective To compare the effectiveness and acceptability of outpatient polypectomy with inpatient polypectomy. Design Pragmatic multicentre randomised controlled non-inferiority study. Setting Outpatient hysteroscopy clinics in 31 UK National Health Service hospitals. Participants 507 women who attended as outpatients for diagnostic hysteroscopy because of abnormal uterine bleeding and were found to have uterine polyps. Interventions Participants were randomly assigned to either outpatient uterine polypectomy under local anaesthetic or inpatient uterine polypectomy under general anaesthesia. Data were collected on women’s self reported bleeding symptoms at baseline and at 6, 12, and 24 months. Data were also collected on pain and acceptability of the procedure at the time of polypectomy. Main outcome measures The primary outcome was successful treatment, determined by the women’s assessment of bleeding at six months, with a prespecified non-inferiority margin of 25%. Secondary outcomes included generic (EQ-5D) and disease specific (menorrhagia multi-attribute scale) quality of life, and feasibility and acceptability of the procedure. Results 73% (166/228) of women in the outpatient group and 80% (168/211) in the inpatient group reported successful treatment at six months (intention to treat relative risk 0.91, 95% confidence interval 0.82 to 1.02; per protocol relative risk 0.92, 0.82 to 1.02). Failure to remove polyps was higher (19% v 7%; relative risk 2.5, 1.5 to 4.1) and acceptability of the procedure was lower (83% v 92%; 0.90, 0.84 to 0.97) in the outpatient group Quality of life did not differ significantly between the groups. Four uterine perforations, one of which necessitated bowel resection, all occurred in the inpatient group. Conclusions Outpatient polypectomy was non-inferior to inpatient polypectomy. Failure to remove a uterine polyp was, however, more likely with outpatient polypectomy and acceptability of the procedure was slightly lower. Trial registration International Clinical Trials Registry 65868569.
- 12 July 2013
- Published by Wiley in The Obstetrician & Gynaecologist
- Vol. 15 (3) , 159-166
Ambulatory hysteroscopy
Key content: Routine diagnostic hysteroscopy under general anaesthesia is an anachronism. Evidence‐based RCOG guidance should be followed to ensure best practice in outpatient hysteroscopy. The role of hysteroscopy in the diagnostic work‐up of abnormal bleeding and reproduction remains unclear and further research is required to elucidate where it can be used most cost‐effectively. Learning objectives: A ‘no touch’ vaginoscopic technique should be employed routinely as this approach reduces pain during diagnostic rigid outpatient hysteroscopy and facilitates operative procedures by improving manipulation of miniature endoscopic equipment. A contemporary outpatient hysteroscopy service should be able to provide surgical treatments for uterine polyps, small fibroids, lost coils, minor uterine anomalies, menstrual disorders and permanent contraception. Ethical issues: Can we justify subjecting women, especially those with significant medical co‐morbidities, to the risks and inconvenience of general anaesthesia for hysteroscopic procedures?
- 12 July 2013
- Published by Wiley in The Obstetrician & Gynaecologist
- Vol. 15 (3) , 159-166
Ambulatory hysteroscopy
Key content: Routine diagnostic hysteroscopy under general anaesthesia is an anachronism. Evidence‐based RCOG guidance should be followed to ensure best practice in outpatient hysteroscopy. The role of hysteroscopy in the diagnostic work‐up of abnormal bleeding and reproduction remains unclear and further research is required to elucidate where it can be used most cost‐effectively. Learning objectives: A ‘no touch’ vaginoscopic technique should be employed routinely as this approach reduces pain during diagnostic rigid outpatient hysteroscopy and facilitates operative procedures by improving manipulation of miniature endoscopic equipment. A contemporary outpatient hysteroscopy service should be able to provide surgical treatments for uterine polyps, small fibroids, lost coils, minor uterine anomalies, menstrual disorders and permanent contraception. Ethical issues: Can we justify subjecting women, especially those with significant medical co‐morbidities, to the risks and inconvenience of general anaesthesia for hysteroscopic procedures?
- 29 July 2011
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 118 (11) , 1292-1301
Does cervical preparation before outpatient hysteroscopy reduce women’s pain experience? A systematic review
Studies examining the use of pharmaceutical (prostaglandins, antiprogestogens) and mechanical (osmotic dilators) dilatation of the cervix before hysteroscopy under general anaesthesia have produced conflicting results regarding their effect on cervical dilatation and trauma during the procedure. To compare the effect on pain and need for cervical dilatation of various methods of cervical preparation before outpatient hysteroscopy. MEDLINE, EMBASE and CINAHL were searched using a combination of the keywords 'hysteroscopy', 'vaginoscopy', 'cervical ripening', 'laminaria', 'progest*', 'prostaglandin', 'oestrogen''cervical preparation' and their associated Medical Subject Headings The Cochrane Library was searched using the keywords 'hysteroscopy' and 'cervical'. There were no limits or filters placed on the searches. Randomised controlled trials that examined women undergoing outpatient hysteroscopy, where the intervention was the use of cervical preparation versus a control or placebo and the outcome was pain assessment. Two reviewers independently selected trials. Data were extracted on pain, the effect on dilatation, adverse effects, trauma and feasibility. Data regarding pain and cervical dilatation were unsuitable for meta-analysis. Meta-analyses were performed for adverse effects and feasibility using the random effects models to calculate the Peto odds ratio. From 585 abstracts, six studies were selected for inclusion in the systematic review. The results suggest that there may be a benefit of using prostaglandins for postmenopausal women; however, there is no high-quality evidence that giving misoprostol before outpatient hysteroscopy reduces the pain experienced by women of reproductive age. There is some evidence that prostaglandins reduce the force and requirement for dilatation of the cervix beyond 5 mm. There is no evidence to recommend the routine administration of mifepristone or misoprostol to women before outpatient hysteroscopy. Cervical priming with vaginal prostaglandins may be considered in postmenopausal women if using hysteroscopic systems >5 mm in diameter.
- 29 July 2011
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 118 (11) , 1292-1301
Does cervical preparation before outpatient hysteroscopy reduce women’s pain experience? A systematic review
Studies examining the use of pharmaceutical (prostaglandins, antiprogestogens) and mechanical (osmotic dilators) dilatation of the cervix before hysteroscopy under general anaesthesia have produced conflicting results regarding their effect on cervical dilatation and trauma during the procedure. To compare the effect on pain and need for cervical dilatation of various methods of cervical preparation before outpatient hysteroscopy. MEDLINE, EMBASE and CINAHL were searched using a combination of the keywords 'hysteroscopy', 'vaginoscopy', 'cervical ripening', 'laminaria', 'progest*', 'prostaglandin', 'oestrogen''cervical preparation' and their associated Medical Subject Headings The Cochrane Library was searched using the keywords 'hysteroscopy' and 'cervical'. There were no limits or filters placed on the searches. Randomised controlled trials that examined women undergoing outpatient hysteroscopy, where the intervention was the use of cervical preparation versus a control or placebo and the outcome was pain assessment. Two reviewers independently selected trials. Data were extracted on pain, the effect on dilatation, adverse effects, trauma and feasibility. Data regarding pain and cervical dilatation were unsuitable for meta-analysis. Meta-analyses were performed for adverse effects and feasibility using the random effects models to calculate the Peto odds ratio. From 585 abstracts, six studies were selected for inclusion in the systematic review. The results suggest that there may be a benefit of using prostaglandins for postmenopausal women; however, there is no high-quality evidence that giving misoprostol before outpatient hysteroscopy reduces the pain experienced by women of reproductive age. There is some evidence that prostaglandins reduce the force and requirement for dilatation of the cervix beyond 5 mm. There is no evidence to recommend the routine administration of mifepristone or misoprostol to women before outpatient hysteroscopy. Cervical priming with vaginal prostaglandins may be considered in postmenopausal women if using hysteroscopic systems >5 mm in diameter.
- 1 January 2011
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 117 (1) , 109-118
Bipolar Radiofrequency Compared With Thermal Balloon Endometrial Ablation in the Office
To estimate the feasibility of local anesthetic endometrial ablation in the office using bipolar radiofrequency endometrial ablation or thermal balloon ablation technologies and to estimate which procedure alleviates heavy menstrual bleeding and improves quality of life more effectively. A single-center, single-blind, randomized controlled trial was conducted based in an office hysteroscopy clinic in a university teaching hospital. Eighty-one women with heavy menstrual bleeding without significant intracavity pathology were randomly allocated to bipolar radiofrequency endometrial ablation or thermal balloon ablation in an office setting, avoiding use of general anesthesia or conscious sedation. The primary outcome assessed was the rate of amenorrhea at 6 months after treatment. Secondary outcomes included procedure-related data (feasibility, pain, acceptability, complications) and health-related quality of life. Amenorrhea rates were higher at 6 months after surgery with bipolar procedures, but not statistically significant (39% compared with 21%, risk ratio 1.9, 95% confidence interval 0.9-4.3, P=.1). All bipolar procedures were successfully completed, whereas the treatment cycle was not completed in 2 of 39 (5%) balloon procedures (P>.1) because of patient discomfort. The office bipolar procedure was significantly shorter, by 6.2 minutes on average (P<.001), and associated with more complete coverage of the endometrial surface (88% compared with 58%, P=.002). Health-related quality of life was significantly improved after both treatments. Office endometrial ablation using the bipolar radiofrequency or thermal balloon procedures is feasible and effective. The bipolar procedure was significantly quicker and achieved a greater degree of endometrial destruction than the thermal balloon, although there was no significant difference in amenorrhea rates at 6 months. ClinicalTrials.gov, www.clinicaltrials.gov, NCT01124357. I.
- 1 January 2011
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 117 (1) , 109-118
Bipolar Radiofrequency Compared With Thermal Balloon Endometrial Ablation in the Office
To estimate the feasibility of local anesthetic endometrial ablation in the office using bipolar radiofrequency endometrial ablation or thermal balloon ablation technologies and to estimate which procedure alleviates heavy menstrual bleeding and improves quality of life more effectively. A single-center, single-blind, randomized controlled trial was conducted based in an office hysteroscopy clinic in a university teaching hospital. Eighty-one women with heavy menstrual bleeding without significant intracavity pathology were randomly allocated to bipolar radiofrequency endometrial ablation or thermal balloon ablation in an office setting, avoiding use of general anesthesia or conscious sedation. The primary outcome assessed was the rate of amenorrhea at 6 months after treatment. Secondary outcomes included procedure-related data (feasibility, pain, acceptability, complications) and health-related quality of life. Amenorrhea rates were higher at 6 months after surgery with bipolar procedures, but not statistically significant (39% compared with 21%, risk ratio 1.9, 95% confidence interval 0.9-4.3, P=.1). All bipolar procedures were successfully completed, whereas the treatment cycle was not completed in 2 of 39 (5%) balloon procedures (P>.1) because of patient discomfort. The office bipolar procedure was significantly shorter, by 6.2 minutes on average (P<.001), and associated with more complete coverage of the endometrial surface (88% compared with 58%, P=.002). Health-related quality of life was significantly improved after both treatments. Office endometrial ablation using the bipolar radiofrequency or thermal balloon procedures is feasible and effective. The bipolar procedure was significantly quicker and achieved a greater degree of endometrial destruction than the thermal balloon, although there was no significant difference in amenorrhea rates at 6 months. ClinicalTrials.gov, www.clinicaltrials.gov, NCT01124357. I.
- Open Access
Local anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis
Objective To compare the effects of different types of local anaesthetic for pain control during outpatient hysteroscopy. Design Systematic review and meta-analysis of randomised controlled trials. Setting Outpatient hysteroscopy clinics. Participants Women undergoing diagnostic or operative hysteroscopy as outpatients—that is, without general anaesthesia. Study selection criteria Medline, Embase, CINAHL, the Cochrane library, and reference lists of relevant studies. Two reviewers independently selected trials. Data were abstracted on quality, characteristics, and results. Results There were 20 trials (2851 participants). Data from 15 of these were meta-analysed in subgroups defined by type of intervention and study quality. Intracervical (standardised mean difference −0.36, 95% confidence interval −0.61 to −0.10, I2=0%) and paracervical (−1.28, −2.22 to −0.35, I2=97%) injections of local anaesthetic significantly reduced the pain in women undergoing hysteroscopy as outpatients, whereas transcervical (−0.11, −0.31 to 0.10, I2=27%) and topical application (−0.32, −0.97 to 0.33, I2= 90%) did not. Meta-regression showed that paracervical injection was superior to the other anaesthetic methods (P=0.04), a finding that was supported by the high quality subgroup of studies. Use of local anaesthetic did not have a significant effect on the incidence of vasovagal episodes (P=0.09). Conclusions Paracervical local anaesthetic injection is the best method of pain control for women undergoing hysteroscopy as outpatients.
Open AccessLocal anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis
Objective To compare the effects of different types of local anaesthetic for pain control during outpatient hysteroscopy. Design Systematic review and meta-analysis of randomised controlled trials. Setting Outpatient hysteroscopy clinics. Participants Women undergoing diagnostic or operative hysteroscopy as outpatients—that is, without general anaesthesia. Study selection criteria Medline, Embase, CINAHL, the Cochrane library, and reference lists of relevant studies. Two reviewers independently selected trials. Data were abstracted on quality, characteristics, and results. Results There were 20 trials (2851 participants). Data from 15 of these were meta-analysed in subgroups defined by type of intervention and study quality. Intracervical (standardised mean difference −0.36, 95% confidence interval −0.61 to −0.10, I2=0%) and paracervical (−1.28, −2.22 to −0.35, I2=97%) injections of local anaesthetic significantly reduced the pain in women undergoing hysteroscopy as outpatients, whereas transcervical (−0.11, −0.31 to 0.10, I2=27%) and topical application (−0.32, −0.97 to 0.33, I2= 90%) did not. Meta-regression showed that paracervical injection was superior to the other anaesthetic methods (P=0.04), a finding that was supported by the high quality subgroup of studies. Use of local anaesthetic did not have a significant effect on the incidence of vasovagal episodes (P=0.09). Conclusions Paracervical local anaesthetic injection is the best method of pain control for women undergoing hysteroscopy as outpatients.
- 10 March 2010
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 117 (5) , 532-539
Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain
Please cite this paper as: Cooper N, Smith P, Khan K, Clark T. Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain. BJOG 2010;117:532–539.Background Vaginoscopy, also known as the ‘no‐touch’ technique, is an alternative method for performing hysteroscopy without the need for a vaginal speculum to view the cervix or cervical instrumentation to grasp and steady the cervix.Objective To examine the effect of a vaginoscopic approach to outpatient hysteroscopy on the patients’ experience of pain, compared with a traditional approach using a vaginal speculum.Search strategy MEDLINE, EMBASE, CINAHL and the Cochrane Library were searched for relevant articles. No filters or restrictions were placed on the searches.Selection criteria Randomised controlled trials (RCTs) that assess pain when comparing the vaginoscopic technique versus a traditional hysteroscopy in the outpatient setting.Data collection and analysis Two reviewers independently selected trials. Data were abstracted on quality, characteristics and results. Meta‐analyses were performed using the random‐effects model to calculate the standardised mean difference (SMD).Main results There were six trials (2851 participants). Data from four of these were meta‐analysed, and we found that the use of the vaginoscopic approach to hysteroscopy was less painful than using the traditional technique (SMD −0.44, 95% CI from −0.65 to −0.22, I2 = 58%). There was no significant difference in the number of failed procedures between groups (P = 0.38).Author’s conclusions The vaginoscopic approach to outpatient hysteroscopy is successful and significantly reduces the pain experienced by patients during the procedure, compared with traditional techniques using a vaginal speculum. Vaginoscopy should become standard practice for endoscopic instrumentation of the uterine cavity in the outpatient setting.
- 10 March 2010
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 117 (5) , 532-539
Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain
Please cite this paper as: Cooper N, Smith P, Khan K, Clark T. Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain. BJOG 2010;117:532–539.Background Vaginoscopy, also known as the ‘no‐touch’ technique, is an alternative method for performing hysteroscopy without the need for a vaginal speculum to view the cervix or cervical instrumentation to grasp and steady the cervix.Objective To examine the effect of a vaginoscopic approach to outpatient hysteroscopy on the patients’ experience of pain, compared with a traditional approach using a vaginal speculum.Search strategy MEDLINE, EMBASE, CINAHL and the Cochrane Library were searched for relevant articles. No filters or restrictions were placed on the searches.Selection criteria Randomised controlled trials (RCTs) that assess pain when comparing the vaginoscopic technique versus a traditional hysteroscopy in the outpatient setting.Data collection and analysis Two reviewers independently selected trials. Data were abstracted on quality, characteristics and results. Meta‐analyses were performed using the random‐effects model to calculate the standardised mean difference (SMD).Main results There were six trials (2851 participants). Data from four of these were meta‐analysed, and we found that the use of the vaginoscopic approach to hysteroscopy was less painful than using the traditional technique (SMD −0.44, 95% CI from −0.65 to −0.22, I2 = 58%). There was no significant difference in the number of failed procedures between groups (P = 0.38).Author’s conclusions The vaginoscopic approach to outpatient hysteroscopy is successful and significantly reduces the pain experienced by patients during the procedure, compared with traditional techniques using a vaginal speculum. Vaginoscopy should become standard practice for endoscopic instrumentation of the uterine cavity in the outpatient setting.
- 7 May 2008
- Published by Springer Nature in Gynecological Surgery
- Vol. 6 (1) , 3-9
Outpatient versus day-case endometrial ablation using the NovaSure™ impedance-controlled ablative system
- 7 May 2008
- Published by Springer Nature in Gynecological Surgery
- Vol. 6 (1) , 3-9
Outpatient versus day-case endometrial ablation using the NovaSure™ impedance-controlled ablative system
- 16 May 2007
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 114 (6) , 676-683
The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation
Objective To determine the feasibility and patient satisfaction of female sterilisation using the Essure™ system in an outpatient hysteroscopy clinic without conscious sedation or general anaesthesia.Design Prospective cohort study.Setting Outpatient hysteroscopy clinic in a large teaching hospital.Population Women undergoing outpatient hysteroscopic sterilisation using the Essure™ system for permanent fertility control.Methods Demographic and procedural data were prospectively collected from 112 consecutive women undergoing outpatient hysteroscopic sterilisation without sedation or general anaesthesia. A hysterosalpingogram (HSG) was performed routinely in all women 3 months after the procedure to confirm bilateral tubal occlusion. Postal questionnaires were sent at this time enquiring about patient satisfaction and experience with the outpatient procedure. Multivariable logistic regression was used to identify factors independently predictive of successful completion of the procedure.Main outcome measures Technical feasibility, predictive factors for technical success (operator, body mass index, uterine size, axis, menstrual phase and cervical stenosis), complications, tubal occlusion on HSG, patient satisfaction and procedure‐related experience.Results Successful bilateral tubal placement of the Essure™ microinserts was achieved in 103/112 (92%, 95% CI 85–96%) women. Nonsecretory phase of the menstrual cycle (P = 0.04) and a clinically normal‐sized uterus (P = 0.003) were independently predictive for successful completion of the outpatient procedure on multivariable modelling. There were no major procedure‐related complications recorded, but transient vasovagal reactions occurred in 5/112 (5%) women. Of the original cohort of 112 women with successful procedures, 84 women were 3 months postprocedure and had undergone a HSG. Bilateral tubal occlusion was confirmed in 83/84 (99%, 95% CI 94–100%) women at 3 months and in 100% at 6 months. Seventy‐six of 84 (91%) had returned the questionnaires, and 70/73 (96%, 95% CI 88–99%) were satisfied with their overall experience of the procedure including radiological follow up, with most reporting being ‘very satisfied’ (64/73, 88%, 95% CI 78–94%).Conclusions Outpatient hysteroscopic sterilisation using the Essure™ system without sedation or general anaesthesia is a successful and safe procedure associated with high rates of patient satisfaction. If practical, women should be scheduled to have their procedures in the proliferative phase of the menstrual cycle to optimise successful placement of Essure™ devices, especially if the uterus is clinically enlarged.
- 16 May 2007
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 114 (6) , 676-683
The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation
Objective To determine the feasibility and patient satisfaction of female sterilisation using the Essure™ system in an outpatient hysteroscopy clinic without conscious sedation or general anaesthesia.Design Prospective cohort study.Setting Outpatient hysteroscopy clinic in a large teaching hospital.Population Women undergoing outpatient hysteroscopic sterilisation using the Essure™ system for permanent fertility control.Methods Demographic and procedural data were prospectively collected from 112 consecutive women undergoing outpatient hysteroscopic sterilisation without sedation or general anaesthesia. A hysterosalpingogram (HSG) was performed routinely in all women 3 months after the procedure to confirm bilateral tubal occlusion. Postal questionnaires were sent at this time enquiring about patient satisfaction and experience with the outpatient procedure. Multivariable logistic regression was used to identify factors independently predictive of successful completion of the procedure.Main outcome measures Technical feasibility, predictive factors for technical success (operator, body mass index, uterine size, axis, menstrual phase and cervical stenosis), complications, tubal occlusion on HSG, patient satisfaction and procedure‐related experience.Results Successful bilateral tubal placement of the Essure™ microinserts was achieved in 103/112 (92%, 95% CI 85–96%) women. Nonsecretory phase of the menstrual cycle (P = 0.04) and a clinically normal‐sized uterus (P = 0.003) were independently predictive for successful completion of the outpatient procedure on multivariable modelling. There were no major procedure‐related complications recorded, but transient vasovagal reactions occurred in 5/112 (5%) women. Of the original cohort of 112 women with successful procedures, 84 women were 3 months postprocedure and had undergone a HSG. Bilateral tubal occlusion was confirmed in 83/84 (99%, 95% CI 94–100%) women at 3 months and in 100% at 6 months. Seventy‐six of 84 (91%) had returned the questionnaires, and 70/73 (96%, 95% CI 88–99%) were satisfied with their overall experience of the procedure including radiological follow up, with most reporting being ‘very satisfied’ (64/73, 88%, 95% CI 78–94%).Conclusions Outpatient hysteroscopic sterilisation using the Essure™ system without sedation or general anaesthesia is a successful and safe procedure associated with high rates of patient satisfaction. If practical, women should be scheduled to have their procedures in the proliferative phase of the menstrual cycle to optimise successful placement of Essure™ devices, especially if the uterus is clinically enlarged.
- Open Access
- 24 April 2006
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 113 (5) , 502-510
Gynaecological oncology: Investigating postmenopausal bleeding for endometrial cancer: cost‐effectiveness of initial diagnostic strategies
Objective To determine the most cost‐effective outpatient testing strategy for diagnosing endometrial cancer in women with postmenopausal bleeding (PMB).Design Decision analysis modelling.Population Women with postmenopausal bleeding.Methods A decision analytic model was constructed to reflect current service provision, which evaluated 12 diagnostic strategies using endometrial biopsy (EB), ultrasonography (USS) (4‐ and 5‐mm endometrial thickness cutoff) and hysteroscopy. Diagnostic probability estimates were derived from systematic quantitative reviews, clinical outcomes from published literature and cost estimates from local and NHS sources.Main outcome measures The cost per additional life year gained (£/LYG) was determined and compared for each diagnostic strategy, and sensitivity analyses were performed.Results Compared with carrying out no initial investigation, a strategy based on initial diagnosis with USS using a 5‐mm cutoff was the least expensive (£11 470/LYG). Initial investigation with EB or USS using a 4‐mm cutoff was comparably cost‐effective (less than £30 000/LYG versus USS with a 5‐mm cutoff) at their most favourable diagnostic performance and at disease prevalence of 10% or more. The strategies involving initial evaluation with test combinations or hysteroscopy alone were not cost‐effective.Conclusions Women presenting for the first time with PMB should undergo initial evaluation with USS or EB.
- 24 April 2006
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 113 (5) , 502-510
Open AccessGynaecological oncology: Investigating postmenopausal bleeding for endometrial cancer: cost‐effectiveness of initial diagnostic strategies
Objective To determine the most cost‐effective outpatient testing strategy for diagnosing endometrial cancer in women with postmenopausal bleeding (PMB).Design Decision analysis modelling.Population Women with postmenopausal bleeding.Methods A decision analytic model was constructed to reflect current service provision, which evaluated 12 diagnostic strategies using endometrial biopsy (EB), ultrasonography (USS) (4‐ and 5‐mm endometrial thickness cutoff) and hysteroscopy. Diagnostic probability estimates were derived from systematic quantitative reviews, clinical outcomes from published literature and cost estimates from local and NHS sources.Main outcome measures The cost per additional life year gained (£/LYG) was determined and compared for each diagnostic strategy, and sensitivity analyses were performed.Results Compared with carrying out no initial investigation, a strategy based on initial diagnosis with USS using a 5‐mm cutoff was the least expensive (£11 470/LYG). Initial investigation with EB or USS using a 4‐mm cutoff was comparably cost‐effective (less than £30 000/LYG versus USS with a 5‐mm cutoff) at their most favourable diagnostic performance and at disease prevalence of 10% or more. The strategies involving initial evaluation with test combinations or hysteroscopy alone were not cost‐effective.Conclusions Women presenting for the first time with PMB should undergo initial evaluation with USS or EB.